156 related articles for article (PubMed ID: 15563864)
1. Management of neuroendocrine differentiated breast carcinoma.
Berruti A; Saini A; Leonardo E; Cappia S; Borasio P; Dogliotti L
Breast; 2004 Dec; 13(6):527-9. PubMed ID: 15563864
[TBL] [Abstract][Full Text] [Related]
2. Postoperative recurrence and the role of adjuvant chemotherapy in patients with pulmonary large-cell neuroendocrine carcinoma.
Iyoda A; Hiroshima K; Moriya Y; Iwadate Y; Takiguchi Y; Uno T; Nakatani Y; Yoshino I
J Thorac Cardiovasc Surg; 2009 Aug; 138(2):446-53. PubMed ID: 19619794
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine carcinomas of the breast.
Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
[TBL] [Abstract][Full Text] [Related]
4. Well-differentiated neurotensin-producing neuroendocrine carcinoma of the breast. Report of a case.
La Rosa S; Usellini L; Riva C; Capella C
Histopathology; 2007 Dec; 51(6):846-7. PubMed ID: 17894802
[No Abstract] [Full Text] [Related]
5. Solid neuroendocrine carcinoma of the breast.
Abbasi NZ; Zahur Z; Sheikh AS; Khan AA; Ali F; Memon KH; Moizuddin SS; Loya A; Barkat N
J Coll Physicians Surg Pak; 2013 Nov; 23(10):820-2. PubMed ID: 24169396
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study.
Hainsworth JD; Spigel DR; Litchy S; Greco FA
J Clin Oncol; 2006 Aug; 24(22):3548-54. PubMed ID: 16877720
[TBL] [Abstract][Full Text] [Related]
7. Large cell neuroendocrine carcinoma of the lung: a retrospective analysis of 144 surgical cases.
Veronesi G; Morandi U; Alloisio M; Terzi A; Cardillo G; Filosso P; Rea F; Facciolo F; Pelosi G; Gandini S; Calabrò F; Casali C; Marulli G; Spaggiari L
Lung Cancer; 2006 Jul; 53(1):111-5. PubMed ID: 16697073
[TBL] [Abstract][Full Text] [Related]
8. [Treatment strategy for neuroendocrine carcinoma of the lung].
Kawase A; Nagai K
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1619-22. PubMed ID: 19838019
[TBL] [Abstract][Full Text] [Related]
9. Primary neuroendocrine carcinoma of the breast, which chemotherapy?
El Hassani LK; Bensouda Y; M'Rabti H; Boutayeb S; Kamouni M; Gamra L; Errihani H
Indian J Cancer; 2009; 46(4):352-4. PubMed ID: 19749475
[No Abstract] [Full Text] [Related]
10. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
11. Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease.
Berruti A; Mosca A; Tucci M; Terrone C; Torta M; Tarabuzzi R; Russo L; Cracco C; Bollito E; Scarpa RM; Angeli A; Dogliotti L
Endocr Relat Cancer; 2005 Mar; 12(1):109-17. PubMed ID: 15788643
[TBL] [Abstract][Full Text] [Related]
12. Fine needle aspiration cytology of neuroendocrine carcinoma of the breast--a case report and review of literature.
Kadir AA; Iyengar KR; Peh SC; Yip CH
Malays J Pathol; 2008 Jun; 30(1):57-61. PubMed ID: 19108413
[TBL] [Abstract][Full Text] [Related]
13. Moderately differentiated neuroendocrine carcinoma (atypical carcinoid) of the larynx: a clinically aggressive tumor.
Gillenwater A; Lewin J; Roberts D; El-Naggar A
Laryngoscope; 2005 Jul; 115(7):1191-5. PubMed ID: 15995505
[TBL] [Abstract][Full Text] [Related]
14. Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy.
Er O; Frye DK; Kau SW; Broglio K; Valero V; Hortobagyi GN; Arun B
Cancer J; 2008; 14(1):62-8. PubMed ID: 18303485
[TBL] [Abstract][Full Text] [Related]
15. A case of cytokeratin 20-positive large-cell neuroendocrine carcinoma of the breast.
Okoshi K; Saiga T; Hisamori S; Iwaisako K; Kobayashi H; Ogawa H
Breast Cancer; 2012 Oct; 19(4):360-4. PubMed ID: 19669861
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.
Crump M; Gluck S; Tu D; Stewart D; Levine M; Kirkbride P; Dancey J; O'Reilly S; Shore T; Couban S; Girouard C; Marlin S; Shepherd L; Pritchard KI
J Clin Oncol; 2008 Jan; 26(1):37-43. PubMed ID: 18025439
[TBL] [Abstract][Full Text] [Related]
17. Large cell neuroendocrine carcinoma of the lung: what we have to do.
Filosso PL
J Thorac Cardiovasc Surg; 2003 May; 125(5):1182-3; author reply 1183-4. PubMed ID: 12771909
[No Abstract] [Full Text] [Related]
18. Metastatic neuroendocrine carcinomas to the head and neck: report of 4 cases and review of the literature.
Salama AR; Jham BC; Papadimitriou JC; Scheper MA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Aug; 108(2):242-7. PubMed ID: 19615663
[TBL] [Abstract][Full Text] [Related]
19. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of adjuvant chemotherapy for pulmonary large cell neuroendocrine carcinoma.
Iyoda A; Hiroshima K; Moriya Y; Takiguchi Y; Sekine Y; Shibuya K; Iizasa T; Kimura H; Nakatani Y; Fujisawa T
Ann Thorac Surg; 2006 Nov; 82(5):1802-7. PubMed ID: 17062251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
